Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Minyuan Chen, Puhong Zhang, Yang Zhao, Nadila Duolikun & Linong Ji. (2022) Where to Initiate Basal Insulin Therapy: Inpatient or Outpatient Department? Real-World Observation in China. Diabetes, Metabolic Syndrome and Obesity 15, pages 3375-3385.
Read now
Read now
LK Billings, M Mocarski, A Basse, B Hunt, WJ Valentine & E Jodar. (2019) Cost of achieving HbA1c and weight loss treatment targets with IDegLira vs insulin glargine U100 plus insulin aspart in the USA. ClinicoEconomics and Outcomes Research 11, pages 271-282.
Read now
Read now
Enrico Torre, Giacomo Matteo Bruno, Sergio Di Matteo, Chiara Martinotti, Martina Oselin, Maria Chiara Valentino, Alessio Parodi, Luigi Carlo Bottaro & Giorgio Lorenzo Colombo. (2018) Cost-minimization analysis of degludec/liraglutide versus glargine/aspart: economic implications of the DUAL VII study outcomes. ClinicoEconomics and Outcomes Research 10, pages 413-421.
Read now
Read now
Alexandra Migdal, Martin Abrahamson, Anne Peters & Nan Vint. (2018) Approaches to rapid acting insulin intensification in patients with type 2 diabetes mellitus not achieving glycemic targets. Annals of Medicine 50:6, pages 453-460.
Read now
Read now
George S Panagoulias & John Doupis. (2014) Clinical utility in the treatment of type 2 diabetes with the saxagliptin/metformin fixed combination. Patient Preference and Adherence 8, pages 227-236.
Read now
Read now
Articles from other publishers (16)
Sharmin Shabnam, Clare L. Gillies, Melanie J. Davies, Terry Dex, Eka Melson, Kamlesh Khunti, David R. Webb, Francesco Zaccardi & Samuel Seidu. (2023) Factors associated with therapeutic inertia in individuals with type 2 diabetes mellitus started on basal insulin. Diabetes Research and Clinical Practice 203, pages 110888.
Crossref
Crossref
Ayodele T. Odularu & Peter A. Ajibade. (2021) Challenge of diabetes mellitus and researchers’ contributions to its control. Open Chemistry 19:1, pages 614-634.
Crossref
Crossref
Julio Rosenstock, Antonio Nino, Joseph Soffer, Lois Erskine, Andre Acusta, Jo Dole, Molly C. Carr, Jason Mallory & Philip Home. (2020) Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial. Diabetes Care 43:10, pages 2509-2518.
Crossref
Crossref
Takahisa Hirose, Ching-Chu Chen, Kyu Jeung Ahn & Jacek Kiljański. (2019) Use of Insulin Glargine 100 U/mL for the Treatment of Type 2 Diabetes Mellitus in East Asians: A Review. Diabetes Therapy 10:3, pages 805-833.
Crossref
Crossref
M. E. Trautmann & J. Vora. (2018) Use of glucagon‐like peptide‐1 receptor agonists among individuals on basal insulin requiring treatment intensification. Diabetic Medicine 35:6, pages 694-706.
Crossref
Crossref
Rahul Khairna, Khalid M. Kamal, Vincent Giannetti, Nilanjana Dwibedi & Jamie McConaha. (2018) Barriers and facilitators to diabetes self-management in a primary care setting – Patient perspectives. Research in Social and Administrative Pharmacy.
Crossref
Crossref
Sujoy Ghosh, A.G. Unnikrishnan, Banshi Saboo, Jothydev Kesavadev, S.R. Aravind, Sarita Bajaj, Rajesh Rajput, Krishna Seshadri, Narsingh Verma, Arvind Gupta, Brij Mohan Makkar, Mihir Saikia, Shailaja Kale, Suresh Damodaran, Ashish Dengra, T.K.M. Eashwar, Anuj Maheshwari, Sharad Pendsey, Sanjeev R. Phatak, Surendra Kumar Sharma, Surya Kumar Singh, A. Ramachandran, Abdul H. Zargar, Shashank R. Joshi & Shaukat M. Sadikot. (2017) Evidence-based recommendations for insulin intensification strategies after basal insulin in type 2 diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 11, pages S507-S521.
Crossref
Crossref
Xiaosu MaJenny Y. ChienJennal JohnsonJames MaloneVikram Sinha. (2017) Simulation-Based Evaluation of Dose-Titration Algorithms for Rapid-Acting Insulin in Subjects with Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antihyperglycemic Medications. Diabetes Technology & Therapeutics 19:8, pages 483-490.
Crossref
Crossref
Wayne Weng, Ye Tian, Edward S. Kimball, Sheldon X. Kong, Jonathan Bouchard, Todd M. Hobbs & Brian Sakurada. (2017) Treatment patterns and clinical characteristics of patients with type 2 diabetes mellitus according to body mass index: findings from an electronic medical records database. BMJ Open Diabetes Research & Care 5:1, pages e000382.
Crossref
Crossref
P. Gaye Knutsen, Cheryl Q. Voelker & Carla C. Nikkel. (2015) Clinical Insights Into a New, Disposable Insulin Delivery Device. Diabetes Spectrum 28:3, pages 209-213.
Crossref
Crossref
Linda Tran, Angela Zielinski, Arpi H. Roach, Jennifer A. Jende, Ann Marie Householder, Emily E. Cole, Shuruq A. Atway, Melinda Amornyard, Mallory L. Accursi, Suzanna W. Shieh & Erin E. Thompson. (2015) Pharmacologic Treatment of Type 2 Diabetes. Annals of Pharmacotherapy 49:6, pages 700-714.
Crossref
Crossref
Alice L Bennett, Pia Munkholm & Jane M Andrews. (2015) Tools for primary care management of inflammatory bowel disease: Do they exist?. World Journal of Gastroenterology 21:15, pages 4457-4465.
Crossref
Crossref
Seiya Shimoda, Mina Okubo, Kotaro Koga, Taiji Sekigami, Junji Kawashima, Daisuke Kukidome, Motoyuki Igata, Norio Ishii, Akiko Shimakawa, Takeshi Matsumura, Hiroyuki Motoshima, Noboru Furukawa, Kenro Nishida & Eiichi Araki. (2015) Insulin requirement profiles in Japanese hospitalized subjects with type 2 diabetes treated with basal-bolus insulin therapy. Endocrine Journal 62:2, pages 209-216.
Crossref
Crossref
Michaela Diamant, Michael A. Nauck, Rimma Shaginian, James K. Malone, Simon CleallMatthew ReaneyDanielle de Vries, Byron J. Hoogwerf, Leigh MacConell & Bruce H.R. Wolffenbuttel. (2014) Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes. Diabetes Care 37:10, pages 2763-2773.
Crossref
Crossref
Mi Young LeeDong Seop ChoiMoon Kyu LeeHyoung Woo LeeTae Sun ParkDoo Man KimChoon Hee ChungDuk Kyu KimIn Joo KimHak Chul JangYong Soo ParkHyuk Sang KwonSeung Hun LeeHee Kang Shin. (2014) Comparison of Acarbose and Voglibose in Diabetes Patients Who Are Inadequately Controlled with Basal Insulin Treatment: Randomized, Parallel, Open-Label, Active-Controlled Study. Journal of Korean Medical Science 29:1, pages 90.
Crossref
Crossref
Seiya Shimoda, Shinsuke Iwashita, Shinji Ichimori, Yasuto Matsuo, Rieko Goto, Takako Maeda, Tomoko Matsuo, Taiji Sekigami, Junji Kawashima, Tatsuya Kondo, Takeshi Matsumura, Hiroyuki Motoshima, Noboru Furukawa, Kenro Nishida & Eiichi Araki. (2013) Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapy. Endocrine Journal 60:10, pages 1207-1214.
Crossref
Crossref